Prospective study of efficacy of prophylactic hemostasis for ulceration post endoscopic submucosal dissection of early gastric tumor.

Prospective study of efficacy of prophylactic hemostasis for ulceration post endoscopic submucosal dissection of early gastric tumor. - Efficacy of hemostasis post ESD.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004394

Enrollment

260

Registered

2010-10-16

Start date

2008-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastric cancer and adenoma

Interventions

Endoscopic submucosal dissection coagulation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed as early gastric cancer or gastric adenoma and are considered as the indication of endoscopic submucosal dissection. Patients who understand the study contents and give informed consents by themselves

Exclusion criteria

Exclusion criteria: 1.Patient with major organ failure(heart failure,renal failure,liver failure, Respiratory failure) 2, Patients who have anticoagulant or antiplatelet therapy and who cannot stop it. 3.Patient with Pacer planting 4. Patients who were judged inappropriate by their physicians.

Design outcomes

Primary

Measure	Time frame
Retio of delayed bleeding(hematemesis or melena required endoscopic hemostasis, decreased the hemoglobin count by more than 2g/dl)	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026